Jazz Pharmaceuticals Announces Date to Release Third Quarter 2012 Results
DUBLIN, Oct. 29, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will host a conference call and live webcast on Thursday, November 8, 2012 at 4:30 p.m. EST/9:30 p.m. GMT. During the call, company management will provide a business and financial update and review third quarter 2012 results.
A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
Investors may participate in the conference call by dialing +1 866-783-2137 in the U.S., or +1 857-350-1596 outside the U.S., and entering passcode 22418849.
An archived version of the webcast will be available for at least one week on the Investors section of the company's website at www.jazzpharmaceuticals.com.
A replay of the conference call will be available through November 15, 2012 by dialing +1 888-286-8010 in the U.S., or +1 617-801-6888 outside the U.S., and entering passcode 43813672.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. For further information, see http://www.jazzpharmaceuticals.com.
SOURCE Jazz Pharmaceuticals plc